On the Russo Edge, @SolomonsWisdom speaks with @Justinbaer, Deputy Markets Editor at @WSJ and author of House of Fidelity: The Rise of the Johnson Dynasty and the Company That Changed American Investing.
▶️ Read the interview and watch the video: https://t.co/9HLhKLh1G7
🎙️Spotify: https://t.co/ddStOr1GIg
#Investing #FinancialMarkets #Biotechnology
🎧 On the latest episode of the Russo Edge Podcast, host @SolomonsWisdom of @RussoPartners interviews Dr. Paul Wotton of @RiceLaunchPad and RBL LLC. Hear how Paul shares insights on Houston's thriving biotech ecosystem and how to turn innovative healthcare research into life-changing treatments.
To listen to the episode, visit: https://t.co/tNojQ4FhJu
Apple Podcasts: https://t.co/vIkUJ31wJA
Watch on YouTube: https://t.co/BRBAZl7Gc3
#Biotech #Startups #Incubator
🎧 @SolomonsWisdom of @RussoPartners chats with Dr. Graig Suvannavejh of @MizuhoAmericas to explore why biotech and pharma are at such a thrilling juncture, with breakthroughs in cancer and Alzheimer’s.
To listen: https://t.co/jOuKiMA09g
YouTube: https://t.co/UfTA1qorsi
Thank you for the coverage @rowanwalrath and @cenmag ! $GANX
Swiss Biotech Restores Motor Function in Mice with #Parkinson’s Disease
https://t.co/skboOciw3E.
.@GainThera is in the spotlight for its innovative AI approach to Parkinson's, with clinical trials revealing symptom reversal in mice. Covered by @FoxBusiness & @FierceBiotech, their work marks a significant advance in #biotech. https://t.co/7rSw4bBJcp
#Parkinsons#SciComms
GT-02287 Completely Restores Motor Function in Mouse Models of Parkinson’s Disease. This week at the 20th WORLDSymposium, we presented data demonstrating the ability of our GT-02287 to restore motor function in a mouse model of #Parkinsons $GANX
https://t.co/8JtVxdn9pF
While there is no consensus on the cause of agitation associated with bipolar disorder or schizophrenia, neurochemical imbalances and anatomical changes in the brain are believed to contribute to its development and clinical manifestations. Learn more. https://t.co/sHhnfUAQsy
We support those living with mental illness on #WMHD2023 & every day. An estimated 64M people live with schizophrenia or bipolar disorder around the world. Learn about agitation, which is common among those living with schizophrenia & bipolar disorder. https://t.co/sHhnfUAQsy
.@NIH awards $45.1 Million NINDS Grant for study of $CLNN's CNM-Au8 in #ALS.
Funding supports an Expanded Access Protocol for CNM-Au8® conducted by @CleneNano in collaboration with @Columbia University and @Synapticure.
Read the full press release: https://t.co/SrWlI9rb7P
$CLNN reports significant long-term survival improvement from CNM-Au8 treatment in HEALEY ALS platform trial compared to PRO-ACT historical controls.
Read the full report here: https://t.co/3G5fXbttAD
Drug discovery and development trends - what will have most impact?
Wed, Jun 28, 2023 4:00 PM - 5:00 PM BST
To secure your place, register for FREE now.
https://t.co/9orl1l1nA0
Sponsored by @DNAScript#DrugDiscovery